Deepika Jalota

Insider Reports History

Entity
Individual
Location
C/O Pmv Pharmaceuticals, Inc., 8 Clarke Drive, Suite 3, Cranbury, NJ
Signature
/s/ Robert Ticktin, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Deepika Jalota:

Stock Role Class Num Shares Value Price $ Report Date Ownership
PMV Pharmaceuticals, Inc. Chief Development Officer Common Stock 118K $178K $1.50 Sep 11, 2024 Direct
PMV Pharmaceuticals, Inc. Chief Development Officer Employee Stock Option (right to buy) 225K Jan 18, 2024 Direct
PMV Pharmaceuticals, Inc. Chief Development Officer Employee Stock Option (right to buy) 125K Aug 13, 2024 Direct

Insider Reports Filed by Deepika Jalota

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PMVP PMV Pharmaceuticals, Inc. Sep 11, 2024 1 -$10.9K 4 Sep 12, 2024 Chief Development Officer
PMVP PMV Pharmaceuticals, Inc. Aug 13, 2024 5 $0 4 Oct 3, 2024 Chief Development Officer
PMVP PMV Pharmaceuticals, Inc. Jan 18, 2024 2 $0 4 Jan 22, 2024 Chief Development Officer
PMVP PMV Pharmaceuticals, Inc. Sep 15, 2023 1 -$27.2K 4 Sep 18, 2023 Chief Development Officer
PMVP PMV Pharmaceuticals, Inc. May 12, 2023 1 $0 4 May 15, 2023 Chief Development Officer
PMVP PMV Pharmaceuticals, Inc. Sep 9, 2022 1 $0 4 Sep 13, 2022 SVP, Regulatory Affairs and QA
PMVP PMV Pharmaceuticals, Inc. Feb 10, 2022 1 $0 4 Feb 28, 2022 SVP, Regulatory Affairs and QA
PMVP PMV Pharmaceuticals, Inc. Aug 17, 2021 3 -$87.6K 4 Aug 18, 2021 SVP, Regulatory Affairs and QA
PMVP PMV Pharmaceuticals, Inc. May 12, 2021 1 $0 4 Jun 8, 2021 SVP, Regulatory Affairs and QA